AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 9.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $389,000 | -89.6% | 51,816 | -84.2% | 0.00% | -93.3% |
| Q3 2021 | $3,737,000 | +39.9% | 327,835 | +65.7% | 0.02% | -53.1% |
| Q1 2020 | $2,671,000 | -45.5% | 197,844 | -22.5% | 0.03% | -5.9% |
| Q3 2019 | $4,904,000 | +281.3% | 255,164 | +616.5% | 0.03% | +277.8% |
| Q4 2018 | $1,286,000 | -93.5% | 35,611 | -88.9% | 0.01% | -90.0% |
| Q3 2018 | $19,830,000 | -23.8% | 322,183 | -16.4% | 0.09% | -23.7% |
| Q2 2018 | $26,023,000 | +744.6% | 385,242 | +578.2% | 0.12% | +807.7% |
| Q1 2018 | $3,081,000 | -37.1% | 56,800 | -30.7% | 0.01% | -13.3% |
| Q4 2017 | $4,899,000 | +38.1% | 81,989 | -59.0% | 0.02% | -42.3% |
| Q3 2015 | $3,548,000 | – | 200,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |